ZA718327B - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
ZA718327B
ZA718327B ZA718327A ZA718327A ZA718327B ZA 718327 B ZA718327 B ZA 718327B ZA 718327 A ZA718327 A ZA 718327A ZA 718327 A ZA718327 A ZA 718327A ZA 718327 B ZA718327 B ZA 718327B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
ZA718327A
Inventor
H Adams
B Herbert
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Publication of ZA718327B publication Critical patent/ZA718327B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
ZA718327A 1971-01-26 1971-12-13 Pharmaceutical composition ZA718327B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10994271A 1971-01-26 1971-01-26

Publications (1)

Publication Number Publication Date
ZA718327B true ZA718327B (en) 1972-09-27

Family

ID=22330411

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA718326A ZA718326B (en) 1971-01-26 1971-12-13 Pharmaceutical composition
ZA718327A ZA718327B (en) 1971-01-26 1971-12-13 Pharmaceutical composition

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ZA718326A ZA718326B (en) 1971-01-26 1971-12-13 Pharmaceutical composition

Country Status (18)

Country Link
AT (2) AT310939B (en)
AU (1) AU465875B2 (en)
BE (2) BE776768A (en)
BR (2) BR7108429D0 (en)
CA (2) CA983850A (en)
DD (2) DD96144A5 (en)
DE (2) DE2163054C3 (en)
DK (2) DK130389B (en)
ES (2) ES398109A1 (en)
FR (2) FR2123278B1 (en)
GB (1) GB1370904A (en)
HU (2) HU162185B (en)
IE (2) IE35910B1 (en)
LU (1) LU64664A1 (en)
NL (2) NL7117401A (en)
NO (2) NO135892C (en)
SE (2) SE391286B (en)
ZA (2) ZA718326B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4917894A (en) * 1988-06-29 1990-04-17 Beecham Inc. Rapid-onset long-duration oral anesthetic composition
AU6883798A (en) * 1997-04-02 1998-10-22 Regents Of The University Of California, The Method of anesthesia
US6326020B1 (en) 1997-05-16 2001-12-04 Children's Medical Center Corporation Local anesthetic formulations
WO2007110221A1 (en) 2006-03-27 2007-10-04 Wex Pharmaceuticals Inc. Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy
US8957207B2 (en) 2009-03-24 2015-02-17 Proteus S.A. Methods for producing phycotoxins
PE20160011A1 (en) 2013-03-15 2016-02-10 Childrens Medical Center COMBINED NEOSAXITOXIN FORMULATIONS FOR PROLONGED LOCAL ANESTHESIA

Also Published As

Publication number Publication date
IE35937L (en) 1972-07-26
FR2123277B1 (en) 1975-06-13
CA983850A (en) 1976-02-17
BR7108429D0 (en) 1973-06-14
ES398109A1 (en) 1975-03-16
DK130389B (en) 1975-02-17
BE776768A (en) 1972-06-16
CA986012A (en) 1976-03-23
IE35910B1 (en) 1976-06-23
FR2123278A1 (en) 1972-09-08
DE2163054C3 (en) 1979-02-01
NO135891B (en) 1977-03-14
NO135892B (en) 1977-03-14
AT310938B (en) 1973-10-25
AU3710171A (en) 1973-06-28
DE2163054A1 (en) 1974-05-02
NL7117401A (en) 1972-07-28
IE35937B1 (en) 1976-07-07
ZA718326B (en) 1972-09-27
SE391286B (en) 1977-02-14
AT310939B (en) 1973-10-25
DK131606B (en) 1975-08-11
HU162347B (en) 1973-02-28
AU3710071A (en) 1973-06-28
NO135891C (en) 1978-05-16
NO135892C (en) 1978-05-16
SE391127B (en) 1977-02-07
AU465875B2 (en) 1975-10-09
FR2123278B1 (en) 1975-08-01
DE2163055A1 (en) 1972-10-12
BR7108428D0 (en) 1973-06-14
ES398108A1 (en) 1975-03-01
FR2123277A1 (en) 1972-09-08
DE2163054B2 (en) 1978-06-01
BE776769A (en) 1972-06-16
NL7117404A (en) 1972-07-28
DD96144A5 (en) 1973-03-12
GB1370904A (en) 1974-10-16
DD96400A5 (en) 1973-03-20
IE35910L (en) 1972-07-26
HU162185B (en) 1973-01-29
DK131606C (en) 1976-01-12
LU64664A1 (en) 1972-08-23
DK130389C (en) 1975-07-14

Similar Documents

Publication Publication Date Title
IE36891L (en) Coronary-dilating composition
AU5119173A (en) Composition
IL39430A0 (en) Slow release pharmaceutical compositions
AU482733B2 (en) Pharmaceutical compositions
ZA727741B (en) Thermofomable compositions
IE35991L (en) Camphor-containing pharmaceutical composition
CY955A (en) Pharmaceutical compositions
GB1393014A (en) Polyurethane-tar compositions
CA974170A (en) Pharmaceutical compositions
IE35910B1 (en) Pharmaceutical composition
ZA713877B (en) Pharmaceutical composition
ZA721363B (en) Pharmaceutical composition
GB1367202A (en) Reflex-reflecting compositions
ZA721169B (en) Pharmaceutical preparation
CY755A (en) Therapeutic composition
ZA723908B (en) Desensitizer composition
IL39516A0 (en) Substituted 4-propoxy-9-fluoronone compounds and pharmaceutical compositions containing them
CA884857A (en) Pharmaceutical composition
CA885421A (en) Pharmaceutical composition
CA884860A (en) Pharmaceutical compositions
CA888155A (en) Pharmaceutical compositions
CA884856A (en) Pharmaceutical compositions
CA888688A (en) Pharmaceutical compositions
CA876689A (en) Pharmaceutical compositions
CA879074A (en) Pharmaceutical compositions